The dental membrane and bone graft substitute market comprises various grafts and membranes that are used for bone regeneration around dental implants or to fill soft or hard tissue defects during dental surgeries. These products help in replacing missing bones, guiding bone regeneration, and protecting the bone from invading soft tissues and cells. Some key membrane products include collagen membranes, non-collagen membranes, and natural bone mineral membranes. Bone graft substitutes include demineralized bone matrix (DBM), synthetic bone grafts, and bone morphogenetic proteins (BMP). The use of bone graft substitutes and membranes helps in better bone regeneration, reduces healing time, and ensures faster restoration of oral functions. The Global dental membrane and bone graft substitute market is estimated to be valued at US$ 1,045.3 Mn in 2024 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the dental membrane and bone graft substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., and Medtronic. Rising awareness regarding oral healthcare and increasing incidence of oral diseases have boosted the demand for dental grafts and bone regeneration procedures. Advancements in membrane and bone graft material technology such as development of synthetic bone grafts and combination products have enhanced treatment outcomes.
The dental membrane and bone graft substitute market is witnessing significant growth owing to the increasing elderly population worldwide and growing prevalence of oral diseases. As per WHO, approximately 3.5 billion people are affected by oral diseases worldwide. Furthermore, rising awareness regarding oral care and the importance of dental implants has increased the number of bone grafting procedures globally. Technological advancements in membrane and bone graft materials, such as the development of synthetic bone grafts and commercially available BMP solutions, have enhanced treatment outcomes and success rates of dental procedures.
Market Trends
Increased adoption of bone morphogenetic proteins: Bone morphogenetic proteins (BMPs) are recombinant human proteins that have the ability to induce new bone formation. Commercially available BMP products are increasingly being used along with bone grafts, which helps to reduce healing times and enhance new bone formation.
Rising popularity of tissue regeneration products: Tissue regeneration products that aid in replacing damaged Periodontal ligament, cementum, alveolar bone, and gum tissues are gaining increased acceptance. The launch of innovative Tissue regeneration and combination products will support the market growth over the forecast period.
Market Opportunities
Emerging markets: Emerging countries, such as India, China, Indonesia, offer significant growth opportunities for players operating in the dental bone grafts market. This is attributed to rising awareness about oral healthcare and increasing healthcare spending in these regions.
Add-on dental services: Players can focus on offering bundling of dental surgical services along with bone grafts and membranes as it provides long-term benefits like increased patient footfall. These positive partnerships are paving new opportunities.
The geographical region where the value of the dental membrane and bone graft substitute market is highly concentrated is North America. This region accounts for the major share of the global market owing to factors such as advanced healthcare infrastructure, high treatment costs, concentrated presence of leading market players, and easy availability of advanced bone grafting and tissue regeneration products. Moreover, the region has a high rate of dental diseases along with a supportive reimbursement framework that drives demand for graft substitutes. Asia Pacific is projected to be the fastest growing regional market for dental membrane and bone graft substitutes. Rapidly developing healthcare systems, rising medical tourism, growing dental issues linked to changing lifestyle habits, and increasing awareness about advanced dental treatments are fueling market growth in the region. Additionally, improving access to dental care, focus of market players on tapping opportunities in emerging countries, and rising disposable incomes are also stimulating demand for substitutes in the Asia Pacific region.
